Information Disclosure of Material Transaction
Click on image above to view full version
PYFAESTHETIC Successfully Holds Cadaver Training to South Korea
Jakarta, 4 April 2023 - PYFAESTHETIC, a subsidiary of PT Pyridam Farma Tbk (PYFA) engaged in the field of dermatology and aesthetics, has successfully held its third cadaver training "PYFAESTHETIC goes to Korea" by inviting 15 doctors consisting
Pyridam Farma Participates in Health Interactive Dialogue Safe Drug Syrup
Jakarta, 21 March 2023 - Pyridam Farma participated in an interactive health dialogue "Safe drug syrup" with the Association of Pharmaceutical Companies (GP Pharmacy) at the Ballroom of the Royal Kuningan Hotel Jakarta to jointly educate the Indonesian people that
Pyfaesthetic Together with Jmbiotech Presents a Range of Anti Aging Treatments for Indonesian Women
Jakarta, 29 July 2022 - Pyridam Farma Tbk (PYFA) through its subsidiary in the field of dermatology and aesthetics, PYFAESTHETIC presents The Pink - aging treatment in collaboration with JMBiotech to meet the needs of doctors for quality anti-aging products. The
Continuing to Expansion & Innovation, Pyridam Farma Officially Acquires PT Ethica Industri Pharmacy
Yenfrino Gunadi (Director of Pyridam Farma), Bedjo Stefanus (SVP of Pyridam Farma), Lee Yan Gwan (President Director of Pyridam Farma), dr Widjanarko Brotosaputro (Director of Pyridam Farma), Indrawati Taurus (Ex President Director of Ethica Pharmaceutical Industry), Susanti Haryanto (Ed Director
Pyridam Farma (PYFA) Presents an AI-Based Cervix Cancer Screening Tool, Cerviray A.I.
Jakarta, 15 July 2022 - Pyridam Farma (PYFA) together with AIDOT Inc. will soon present innovative healthcare products for the people of Indonesia, namely Cerviray A.I., a portable cervical cancer detection tool that can help women in early detection of
POSTPONEMENT PUBLIC EXPOSE (“PUBLIC EXPOSE”) PT PYRIDAM FARMA TBK
We, PT Pyridam Farma Tbk., (the “Company”), would like to notify the postponement on the Public Expose that is originally planned to be electronically held on Wednesday, July 20, 2022 to become as follows: Day/Date : Thursday, July 28, 2022 Time
PUBLIC EXPOSE (“PUBLIC EXPOSE”) PT PYRIDAM FARMA TBK
The Board of Directors of PT Pyridam Farma Tbk., (hereinafter referred to as the “Company”) domiciled in South Jakarta, hereby invites the shareholders to attend the Electronic Public Expose (“Public Expose”) of the Company which will be held on: Day/Date
More Expansion! PT Pyridam Farma Tbk (PYFA) Acquisition of PT Ethica Industri Pharmaceuticals
Jakarta, 13 June 2022 - After successfully acquiring PT Holi Pharma at the end of 2021, this time PT Pyridam Farma Tbk with the issuer code PYFA again signed an agreement with companies that are part of the Fresenius Kabi
Sales of Pyridam Farma Tbk and its subsidiaries (PYFA Group) Increase 127% to Rp. 630.5 Billion in 2021
Jakarta, May 6, 2022 - PT Pyridam Farma Tbk. and its subsidiary (PYFA Group) recorded a significant increase in net sales, which increased by 127% to Rp. 630.5 Billion in 2021 compared to Rp. 277.4 billion in 2020. This increase